In males, the circulating levels of NLRP3 seemed to decrease with increase in MetS components but the trend was not statistically significant (p = 0.06); however, in females, there was a significant increase in circulating levels of NLRP3 with number of MetS components (p = 0.038). Here, NLRP3 is linked to metabolic syndrome.